Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000158499 | SCV000208434 | benign | not specified | 2014-10-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000367350 | SCV000386347 | likely benign | Left ventricular noncompaction cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000272990 | SCV000386348 | likely benign | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000309344 | SCV000386349 | likely benign | MYH7-related skeletal myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003320118 | SCV000386350 | likely benign | Myosin storage myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000267849 | SCV000386351 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000322984 | SCV000386352 | likely benign | Scapuloperoneal myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620627 | SCV000740194 | likely benign | Cardiovascular phenotype | 2017-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000267849 | SCV001002908 | likely benign | Hypertrophic cardiomyopathy | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001188911 | SCV001356088 | likely benign | Cardiomyopathy | 2018-11-27 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001188911 | SCV004819145 | likely benign | Cardiomyopathy | 2024-07-29 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723729 | SCV001956582 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723729 | SCV001966482 | likely benign | not provided | no assertion criteria provided | clinical testing |